MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Molecular Pharmacology Fast Forward
First published on November 3, 2005; DOI: 10.1124/mol.105.019356

0026-895X/06/6902-558-563$20.00
Mol Pharmacol 69:558-563, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019356v1
69/2/558    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groot-Kormelink, P. J.
Right arrow Articles by Sivilotti, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groot-Kormelink, P. J.
Right arrow Articles by Sivilotti, L. G.

Constraining the Expression of Nicotinic Acetylcholine Receptors by Using Pentameric Constructs

Paul J. Groot-Kormelink, Steven Broadbent, Marco Beato, and Lucia G. Sivilotti

Department of Pharmacology, University College London, London, United Kingdom

Much of our understanding of ligand-gated ion channels comes from heterologous expression studies. However, this technique cannot produce receptors with a predetermined subunit composition for channels formed by several different subunits and cannot insert a single mutation copy if the subunit of interest is present in several copies in the channel. Here, we describe a novel approach that overcomes these problems by expressing pentameric constructs, in which the code of the five subunits is linked (i.e., beta4_beta4_{alpha}3_beta4_{alpha}3). This is the first time that a concatemer of the complete pentameric receptor has been expressed for channels in the cysteine-loop superfamily. The presence of the linker did not change the agonist or antagonist sensitivity of {alpha}3beta4 nicotinic receptors. We show evidence that the expressed receptors were made up of {alpha}3 and beta4 subunits in one pentameric fusion protein as designed in the construct. This approach can be applied to any nicotinic superfamily receptor to produce channels with a defined subunit arrangement and to introduce specific mutations at any desired location of the pentameric fusion protein.

Received September 28, 2005; accepted November 3, 2005

Address correspondence to: Dr. Lucia Sivilotti, Department of Pharmacology, University College London, Gower Street, London, WC1E 6BT, United Kingdom. E-mail: l.sivilotti{at}ucl.ac.uk


Related articles in MolPharm:

Pretty Subunits All in a Row: Using Concatenated Subunit Constructs to Force the Expression of Receptors with Defined Subunit Stoichiometry and Spatial Arrangement
Michael M. White
MolPharm 2006 69: 407-410. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 JGPHome page
J. T. Sack, O. Shamotienko, and J. O. Dolly
How to Validate a Heteromeric Ion Channel Drug Target: Assessing Proper Expression of Concatenated Subunits
J. Gen. Physiol., May 1, 2008; 131(5): 415 - 420.
[Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Broadbent, P. J. Groot-Kormelink, P. A. Krashia, P. C. Harkness, N. S. Millar, M. Beato, and L. G. Sivilotti
Incorporation of the beta3 Subunit Has a Dominant-Negative Effect on the Function of Recombinant Central-Type Neuronal Nicotinic Receptors
Mol. Pharmacol., October 1, 2006; 70(4): 1350 - 1357.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics